In this report, we document the results of a cross-sectional study of pancreatic VMAT2 in healthy controls and patients with T1DM and type 2 diabetes mellitus (T2DM) using PET with [18F]FP-(+)-DTBZ to estimate pancreatic BCM. The gene discussed is SLC18A2; the disease is type 2 diabetes mellitus.